SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000920465-17-000092
Filing Date
2017-12-29
Accepted
2017-12-29 17:04:58
Documents
1
Period of Report
2017-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151458508417039.html 4  
1 FORM 4 wf-form4_151458508417039.xml 4 4023
  Complete submission text file 0000920465-17-000092.txt   5374
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1960 KIRBY ROAD MCLEAN VA 22101
Business Address
Chawla Lakhmir S (Reporting) CIK: 0001646626 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36282 | Film No.: 171282582